In a national first, the Food and Drug Administration has given Intellia Therapeutics the go-ahead to begin testing a drug that uses CRISPR gene editing in vivo. In biology, in vivo means within an organism, rather than in something like a petri dish, and Intellia’s offering is the first time ever that the FDA has approved such […]
The post FDA Clears First Study of CRISPR Gene-Editing in Human Patients appeared first on Good News Network.
from Good News Network https://ift.tt/AzgS3mK
via IFTTT
No comments:
Post a Comment